Did you know that 60% of the Drosophila melanogaster (or fruit fly) genome is homologous to that of humans? That makes a valuable argument to use flies as a relevant model to study human health.
Dr. Trudy Mackay, Director of Clemson University Centre for Human Genetics, explains how the theory of evolution and the advancement of genetics have led the PrecisionTox project to select Drosophila as one organism models to develop methods to accelerate chemical risk assessment to better protect humans and the environment and ultimately replace mammalian models.
PrecisionTox is a EU-funded project (Grant Agreement n° 965406) dedicated to tackling chemical pollution, the first cause of deaths in the world, without the need of mammalian animal testing.
To learn more, visit our project website and follow us on Twitter : @PrecisionTox